Treatment with oral semaglutide (Rybelsus) significantly improved motivation measures in patients with major depressive ...

Does it matter when in childhood bullying happens? New research suggests recent bullying hits hardest and that early support ...

ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the opening of study ...

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...

Spravato (esketamine) is a nasal spray used for depression and was approved by the FDA in 2019. It is specifically for treatment-resistant depression, meaning depression symptoms that have not gotten ...

Many people with idiopathic hypersomnia (IH) experience depressive symptoms. The cause of IH is unknown, so it’s hard to say whether one condition causes the other. Many people with idiopathic ...

Johnson & Johnson’s oral add-on drug significantly improved depressive symptoms and sleep outcomes in a phase 3 trial for patients who previously did not benefit from antidepressants alone. The ...

Please provide your email address to receive an email when new articles are posted on . Depressive symptoms increased in high school students from 28.4% in 2007 to 42.3% in 2021. The largest increases ...

The approval of medicines called second-generation antipsychotics has allowed major depressive disorder (MDD) and other conditions linked to it to be treated. A person with MDD is usually prescribed ...